Viveve Medical Inc
OTC:VIVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Viveve Medical Inc
Selling, General & Administrative
Viveve Medical Inc
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Viveve Medical Inc
OTC:VIVE
|
Selling, General & Administrative
-$13.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-18%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
-$7.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
-$8.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
-$12.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
-$2.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
Viveve Medical Inc
Glance View
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The firm's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The firm's subsidiary includes Viveve, Inc. and Viveve BV.
See Also
What is Viveve Medical Inc's Selling, General & Administrative?
Selling, General & Administrative
-13.5m
USD
Based on the financial report for Sep 30, 2022, Viveve Medical Inc's Selling, General & Administrative amounts to -13.5m USD.
What is Viveve Medical Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-18%
Over the last year, the Selling, General & Administrative growth was -7%. The average annual Selling, General & Administrative growth rates for Viveve Medical Inc have been 22% over the past three years , 11% over the past five years , and -18% over the past ten years .